CoChat

Dance of The Golgi: Understanding Golgi Dynamics in Cancer Metastasis

Open access
Bajaj, Rakhee, Warner, Amanda N., Fradette, Jared F., Gibbons, Don L. · 2022 · Cells

The DOI matches its Crossref record; 143 of the 143 references it cites were found in a registry or an index.

Abstract

The Golgi apparatus is at the center of protein processing and trafficking in normal cells. Under pathological conditions, such as in cancer, aberrant Golgi dynamics alter the tumor microenvironment and the immune landscape, which enhances the invasive and metastatic potential of cancer cells. Among these changes in the Golgi in cancer include altered Golgi orientation and morphology that contribute to atypical Golgi function in protein trafficking, post-translational modification, and exocytosis. Golgi-associated gene mutations are ubiquitous across most cancers and are responsible for modifying Golgi function to become pro-metastatic. The pharmacological targeting of the Golgi or its associated genes has been difficult in the clinic; thus, studying the Golgi and its role in cancer is critical to developing novel therapeutic agents that limit cancer progression and metastasis. In this review, we aim to discuss how disrupted Golgi function in cancer cells promotes invasion and metastasis.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3390/cells11091484

Cites

143 of 143 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Golgi orientation, vesicular trafficking, and secretion are dysregulated upon malignant transformation. The functions, morphology, and orientation of the Golgi within a cancer cell (right) are modified, resulting in targeted exocytosis of invasive components, such as MMPs (purple dots) or cytokines (orange dots). This secretion mediates degradation of the ECM comprising of collagens, proteoglycans, etc., as well as suppression of the immune landscape. Malignant cells also have altered glycobiology and glycocalyces, such as specific surface PTMs, including sialyl Tn (purple square and circle) and high mannose N-glycans (orange circles), which promote invasion and intravasation. The unique proteoglycans and PTMs on cancer cells can serve as diagnostic or prognostic biomarkers for early cancer detection or personalized therapeutics.
Figure 1 Golgi orientation, vesicular trafficking, and secretion are dysregulated upon malignant transformation. The functions, morphology, and orientation of the Golgi within a cancer cell (right) are modified, resulting in targeted exocytosis of invasive components, such as MMPs (purple dots) or cytokines (orange dots). This secretion mediates degradation of the ECM comprising of collagens, proteoglycans, etc., as well as suppression of the immune landscape. Malignant cells also have altered glycobiology and glycocalyces, such as specific surface PTMs, including sialyl Tn (purple square and circle) and high mannose N-glycans (orange circles), which promote invasion and intravasation. The unique proteoglycans and PTMs on cancer cells can serve as diagnostic or prognostic biomarkers for early cancer detection or personalized therapeutics.CC BY · PubMed Central
Figure 2 Regulation of Golgi morphology states in cancer. The Golgi oscillates dynamically between three main defined morphological states: the condensed (left Golgi), the elongated (middle Golgi), or the fragmented (right Golgi). Zeb1-mediated EMT orchestrates Golgi condensation by repressing the epithelial miRNA, namely, miR-200, and upregulating PAQR11. PAQR11 is a Golgi scaffold protein that mediates Golgi organization and secretion of pro-metastatic factors. The elongated Golgi morphology is maintained via the PITPNC1–RAB1B–GOLPH3–MYO18A complex, where GOLPH3 links vesicles to myosin motors and facilitates movement along actin filaments. Additionally, other Golgi matrix proteins, namely, GM130 and GRASP65, also interact with various Golgi factors to promote the elongated ribbon-like structures, which is necessary for cancer cell invasion and vesicular trafficking. Loss of these matrix proteins prevents organelle stacking, thereby leading to a fragmented Golgi architecture, which is commonly seen during mitosis. Moreover, in prostate cancer, a disrupted Golgi promotes invasion through dysregulated vesicle interaction with RAB6A, which results in diminished interactions with myosin, MYOIIA, and fewer fusion events.
Figure 2 Regulation of Golgi morphology states in cancer. The Golgi oscillates dynamically between three main defined morphological states: the condensed (left Golgi), the elongated (middle Golgi), or the fragmented (right Golgi). Zeb1-mediated EMT orchestrates Golgi condensation by repressing the epithelial miRNA, namely, miR-200, and upregulating PAQR11. PAQR11 is a Golgi scaffold protein that mediates Golgi organization and secretion of pro-metastatic factors. The elongated Golgi morphology is maintained via the PITPNC1–RAB1B–GOLPH3–MYO18A complex, where GOLPH3 links vesicles to myosin motors and facilitates movement along actin filaments. Additionally, other Golgi matrix proteins, namely, GM130 and GRASP65, also interact with various Golgi factors to promote the elongated ribbon-like structures, which is necessary for cancer cell invasion and vesicular trafficking. Loss of these matrix proteins prevents organelle stacking, thereby leading to a fragmented Golgi architecture, which is commonly seen during mitosis. Moreover, in prostate cancer, a disrupted Golgi promotes invasion through dysregulated vesicle interaction with RAB6A, which results in diminished interactions with myosin, MYOIIA, and fewer fusion events.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 143 references

Cited by

See all 74

Metadata

Authors
Bajaj, R., Warner, A. N., Fradette, J. F., & Gibbons, D. L.
Affiliations
  • The University of Texas MD Anderson Cancer Center (US)
  • Department of Thoracic/Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030, USA
Corresponding author
Gibbons, Don L.
Venue
Cells
Publisher
MDPI AG
Published
2022-04-28
Volume
11
Issue
9
Pages
1484
ISSN
2073-4409 (ISSN-L)
OpenAlex
W4280643510
Cited by
74
References
143
Citations by year
2026: 21 · 2025: 19 · 2024: 18 · 2023: 11 · 2022: 4
FWCI
1.87
Type
journal article
Language
en
Open access
Locations
  • Cells (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • Digital Commons-TMC (Texas Medical Center) (submittedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
  • NIH (R37CA214609, 2P50CA070907-21A, RP160652-P3, RP170067)
  • CPRIT-MIRA (R37CA214609, 2P50CA070907-21A, RP160652-P3, RP170067)
  • Rexanna’s Foundation for Fighting Lung Cancer (R37CA214609, 2P50CA070907-21A, RP160652-P3, RP170067)
  • CPRIT Research Training Grant (R37CA214609, 2P50CA070907-21A, RP160652-P3, RP170067)
  • The University of Texas MD Anderson Lung Cancer Moon Shots Program (R37CA214609, 2P50CA070907-21A, RP160652-P3, RP170067)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Cellular transport and secretion
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Extracellular vesicles in disease
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Caveolin-1 and cellular processes
Keywords
Golgi apparatus, Golgi dynamics, metastasis, tumor microenvironment, Golgi morphology, protein trafficking, post-translational modification, exocytosis, tumor invasion
MeSH terms
Golgi Apparatus, Humans, Neoplasms, Protein Transport, Tumor Microenvironment

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Dance of The Golgi: Understanding Golgi Dynamics in Cancer Metastasis. https://app.cochat.ai/papers/10.3390/cells11091484
The paper
Bajaj, R., Warner, A. N., Fradette, J. F., & Gibbons, D. L. (2022). Dance of The Golgi: Understanding Golgi Dynamics in Cancer Metastasis. Cells. https://doi.org/10.3390/cells11091484

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.